New breath of hope: inhaled drug aims to protect kids' airways during surgery
NCT ID NCT06624696
Summary
This study is testing whether inhaling a medication called penehyclidine before surgery can prevent breathing problems in children who are at higher risk. It involves 204 children aged 3 to 7 who are having eye surgery and have risk factors like recent colds, wheezing, or family history of asthma. Children will randomly receive either the real medication or a placebo (inactive substance) to see which group has fewer breathing complications during and after their procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIOPERATIVE RESPIRATORY ADVERSE EVENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shenzhen Eye Hospital
NOT_YET_RECRUITINGShenzhen, Guangdong, 518040, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongshan Ophthalmic Center, Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510060, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.